logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Coda Therapeutics, Inc.

Calculating rank
USPTO Granted Patents = 23

% Expired Patents = 65.2


Trademarks = 1

Forward Citations = 142

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Colin Richard Green (17 out of 32 patents)

silverMedal David Laurence Becker (17 out of 21 patents)

bronzeMedal Bradford James Duft (12 out of 20 patents)

4.  Richard Colin Green (4 out of 4 patents)

5.  Wilda Laux (2 out of 6 patents)

6.  Anthony Phillips (2 out of 5 patents)

7.  Scott Bannan (2 out of 3 patents)

8.  Grove Matsuoka (2 out of 3 patents)

9.  David Pool (2 out of 3 patents)

10.  Tracey Sunderland (2 out of 3 patents)

11.  David Eisenbud (2 out of 3 patents)

12.  Yeri Kim (1 out of 3 patents)

13.  David Lawrence Becker (1 out of 1 patent)

14.  Anthony Phillips (1 out of 1 patent)

15.  Becker David Dr Dr (0 patent)


23 patents:

1. 12767947 - CHANNEL MODULATORS (2026-10-20),
2. 9937197 - Wound healing compositions and treatments (2018-04-10),
3. 9932592 - Formulations comprising antisense nucleotides to connexins (2018-04-03),
4. 9738892 - Treatment of fibrotic conditions (2017-08-22),
5. 9637745 - Impaired wound healing compositions and treatments (2017-05-02),
6. 9561311 - Medical devices (2017-02-07),
7. 9457044 - Methods and compositions for wound healing (2016-10-04),
8. 9248141 - Methods of treatment by administering anti-connexin proteins and mimetics (2016-02-02),
9. 9193754 - Formulations comprising antisense nucleotides to connexins (2015-11-24),
10. 9156896 - Wound healing compositions and treatments (2015-10-13),
11. 9035037 - Medical devices (2015-05-19),
12. 9029339 - Impaired wound healing compositions and methods (2015-05-12),
13. 8975237 - Treatment of fibrotic conditions (2015-03-10),
14. 8815819 - Anti-connexin compounds targeted to connexins and methods of use thereof (2014-08-26),
15. 8685940 - Impaired wound healing compositions and treatments (2014-04-01),
Company Overview
Coda Therapeutics, Inc. is a biotechnology company based in San Diego, California, focused on developing innovative therapies for cancer treatment. The company specializes in harnessing advanced technologies to create targeted therapies that aim to improve patient outcomes. Coda Therapeutics is dedicated to addressing unmet medical needs through its research in novel drug delivery systems and therapeutic modalities, positioning itself at the forefront of cancer therapeutics and personalized medicine.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

Coda Therapeutics, Inc. USPTO Patent Assignee Logo
23 Patents

#263 in San Diego, CA

#3,426 in California

#14,456 in US

#27,744 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Coda Therapeutics, Inc.

Forward Citations = 142

14 inventors:

goldMedal Colin Richard Green (17 out of 32 patents)

silverMedal David Laurence Becker (17 out of 21 patents)

bronzeMedal Bradford James Duft (12 out of 20 patents)

4.  Richard Colin Green (4 out of 4 patents)

5.  Wilda Laux (2 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Coda Therapeutics, Inc.. Retrieved from https://idiyas.com/company/coda-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…